Literature DB >> 7137200

Alcoholism as a risk factor in methadone maintenance. A randomized controlled trial.

B Stimmel, R Hanbury, V Sturiano, D Korts, G Jackson, M Cohen.   

Abstract

A randomized controlled trial of 625 addicts on methadone maintenance identified 105 (17 percent) as active alcoholics, 47 (8 percent) as inactive alcoholics, and 473 (75 percent) as nonalcoholics. Subjects were followed for up to 29 months (mean 53.7 weeks) to assess the influence of alcoholism on the rehabilitative process. During the study, alcohol consumption significantly decreased (p less than 0.001) in active alcoholics. Indexes of productive activity on entry or during follow-up revealed no significant differences between active alcoholics and other patients with the exception of alcohol-related hospitalizations (p less than 0.001). Behavioral indexes consistently improved with treatment in all patients, being greatest among active alcoholics (p less than 0.01). During the study, 28 (7 percent) of 399 nonalcoholics were recategorized as active alcoholics, and remission from alcoholism was noted in 28 (27 percent) of patients who were initially classified as alcoholic. These findings suggest that alcoholism does not significantly affect rehabilitation from narcotic use and therefore should not be cause for detoxification from methadone maintenance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137200     DOI: 10.1016/0002-9343(82)90402-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  A comparative study of alcoholics and drug addicts in an Arabian Gulf country.

Authors:  K Chaleby
Journal:  Soc Psychiatry       Date:  1986

Review 2.  Pharmacotherapy of dual substance abuse and dependence.

Authors:  George A Kenna; Darci M Nielsen; Patricia Mello; Alison Schiesl; Robert M Swift
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  [Not Available].

Authors:  F Lehmann; P Lauzon
Journal:  Can Fam Physician       Date:  1989-08       Impact factor: 3.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.